Feasibility assessment of a novel selective peptide derivatization strategy for sensitivity enhancement for the liquid chromatography/tandem mass spectrometry bioanalysis of protein therapeutics in serum.
about
Feasibility assessment of a novel selective peptide derivatization strategy for sensitivity enhancement for the liquid chromatography/tandem mass spectrometry bioanalysis of protein therapeutics in serum.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Feasibility assessment of a no ...... protein therapeutics in serum.
@en
Feasibility assessment of a no ...... protein therapeutics in serum.
@nl
type
label
Feasibility assessment of a no ...... protein therapeutics in serum.
@en
Feasibility assessment of a no ...... protein therapeutics in serum.
@nl
prefLabel
Feasibility assessment of a no ...... protein therapeutics in serum.
@en
Feasibility assessment of a no ...... protein therapeutics in serum.
@nl
P2093
P2860
P356
P1476
Feasibility assessment of a no ...... protein therapeutics in serum.
@en
P2093
Anne-Françoise Aubry
Mark E Arnold
P2860
P304
P356
10.1002/RCM.6836
P50
P577
2014-04-01T00:00:00Z